In the second quarter of fiscal year 2018, the earnings of
Aurobindo Pharma increased by 17.3 per cent to Rs 4,354 crore. In the second
quarter of fiscal year 2017, Aurobindo Pharma's income was Rs 3,713 crore.
In the second quarter, the Aurobindo Pharma Abitata has
increased from Rs 867.3 crore to Rs 1,035 crore. On the basis of the second
quarter, Aurobindo Pharma's Abitda margin has increased from 23.4 per cent to
23.8 per cent.

No comments:
Post a Comment